SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXCH.L Regulatory News (XCH)

  • There is currently no data for XCH

Acquisition

8 Nov 2012 07:00

RNS Number : 6057Q
Xchanging PLC
08 November 2012
 



8 November 2012

 

Xchanging plc

Acquisition of Italian fund administration business AR Enterprise S.r.l.

 

 

 

Xchanging plc ('Xchanging'), the business process, procurement and technology services provider and integrator, today announces that its subsidiary, Kedrios S.p.A. ('Kedrios'), has acquired 100% of the share capital of AR Enterprise S.r.l. ('AR'). AR, based in Milan, is a leading provider of software packages and comprehensive IT solutions for the securities brokerage and asset management industry in Italy, with a customer base comprising more than 100 leading financial institutions.

 

Xchanging will combine the newly acquired AR business with Kedrios, which operates in the same business segment.

 

The acquisition will provide a significantly improved proprietary technology platform and a much improved customer base to Kedrios. Operating synergies will also lead to reductions in the combined cost base, with restructuring costs self-funded from existing and future cash flow generated by the combined business.

 

The acquisition will enable Xchanging to accelerate the profit growth of the combined business, creating a stronger profitable business with scale and the ability to compete successfully in the Italian financial services, technology services and business processing markets. It was planned that Kedrios would reach a breakeven run rate by the end of 2013; but without scale and significant investment in upgraded technology, its ability to sustain a strong competitive position in the long term would have remained weak.

 

The initial consideration is €12.85 million, payable in cash on completion, with further consideration contingent upon achieving defined performance criteria. The contingent payments comprise €3.21 million ("First Contingent Payment") payable in Q1 2014 and up to a maximum of €12.49 million ("Second Contingent Payment") payable by the end of Q2 2015, resulting in a total maximum consideration of up to €28.55 million.

 

Xchanging has acquired AR's gross assets of €6.3 million and net assets of €2.6 million. Revenues for Kedrios and AR in 2011 were €12.5 million and €14.9 million respectively. The pre-tax profit attributable to AR was €3.3 million for the year ended 31 December 2011, and averaged €2.6 million over the last 3 years. The acquisition is anticipated to be earnings accretive, on an adjusted basis, from 2013 onwards.

 

Immediately prior to the acquisition Xchanging recapitalised Kedrios with €12.85 million which diluted the shareholding of partner SIA S.p.A. ("SIA") from 49% down to 1.3%. This dilution contributes to the stated objective of simplifying Xchanging's corporate structure by reducing this minority interest significantly.

 

The contingent payments for the acquisition of AR are subject to achieving certain performance criteria as follows:

 

·; The First Contingent Payment is subject to certain technology migration criteria being achieved;

 

·; The Second Contingent Payment is subject to the achievement of certain operating profit targets of the combined business for the year ending 31 December 2014. The full payout would be made when the combined operating profit of Kedrios and AR reaches €12.5 million. This is payable in increments as follows:

a) Between €0.0 and €9.64 million will be paid pro rata for 2014 operating profit of between €0.0 million to €6.0 million; and

b) €0.30 will be paid for each incremental €1 of 2014 operating profit achieved above €6.0 million up to €8.0 million; and

c) €0.50 will be paid for each incremental €1 of 2014 operating profit achieved above €8.0 million up to €12.5 million.

 

The four majority shareholders of AR were also directors of AR. They will remain with the combined business to ensure continuity and to support achievement of the performance criteria described above. The four directors are: Stefano Brioschi, who will become co-CEO of the newly combined business, alongside the current Kedrios CEO; Peter Arnold, who will also become a director of the combined business; and Michele Hessel and Roberto Roncoroni who will continue to support the combined business.

 

Under the existing agreements with SIA, Xchanging requires SIA's approval should it wish to transfer ownership of its shares in Kedrios. With respect to SIA's remaining 1.3% shareholding in Kedrios, SIA have a put option which can be exercised from January 2014 and Xchanging have a call option which can be exercised from January 2016.

 

In a separate transaction Xchanging and SIA have agreed proposed amendments ('Amendments') to the transfer rights of Xchanging and the timing on when the put and call options can be exercised. These Amendments mean (i) that Xchanging would be able to transfer ownership of its shares in Kedrios without the approval of SIA; and (ii) in the event of such a transfer occurring, either party would be entitled to exercise their respective put or call option at that time.

 

SIA is classified as a related party by the UK Listing Authority as a result of their 49% shareholding in Kedrios immediately prior to the recapitalisation and acquisition. The Amendments are therefore classified as a related party transaction by the UK Listing Authority and are conditional on the approval of Xchanging shareholders at a general meeting of Xchanging.

 

A circular setting out further details of the Amendments, together with the notice to convene a general meeting and the form of proxy for use at the general meeting, will be posted to Xchanging shareholders as soon as practicable.

 

Commenting on today's announcement, Ken Lever, Xchanging's CEO said: "The opportunity to acquire AR has enabled us to resolve the weak strategic position of Kedrios and to create a strong combined business with scale and strong profitability. We are delighted to have this foundation from which to establish a market leading position in the industry in Italy."

 

Commenting on the acquisition, Stefano Brioschi, AR's CEO said: "We are delighted to become part of Xchanging. The combined market presence of AR and Xchanging will enable us to provide a better quality service to our combined customer base."

 

 

 

Enquiries

Xchanging plc Tel: +44 (0) 207 780 6999

David Bauernfeind, Chief Financial Officer

Alexandra Hockenhull, Head of Corporate Communications

and Investor Relations

 

Maitland Tel: +44 (0) 207 379 5151

George Hudson

Emma Burdett

Daniel Yea

 

Conference Call

David Bauernfeind and Alexandra Hockenhull will host a conference call for analysts and investors to discuss this announcement at 07:30 GMT on Thursday 8 November 2012. The conference call telephone number is +44 (0)1452 555 566 and conference ID is 59659384.

 

For individuals unable to participate in the conference call, a telephone replay will be available until Thursday 21 November 2012. Please telephone +44 (0)1452 550 000 (conference ID 59659384).

 

 

Xchanging

 

What we are

Xchanging provides business processing, technology and procurement services internationally for customers across multiple industries.

 

What we do

Xchanging brings innovation, thought leadership and passion to its customers' businesses so as to enhance performance and value. Our values are embedded into everything we do.

 

What we want to be

Xchanging wants to be regarded as the best provider in its chosen markets by delivering services that are recognised for outstanding quality, reliability and innovation.

 

www.xchanging.com

Cautionary Statement: 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Xchanging's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approval or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLFFIILTLDIIF
Date   Source Headline
7th Apr 20157:00 amRNSMM4 amendment to earn-out terms
1st Apr 20152:06 pmRNSBlocklisting Interim Review
31st Mar 20154:54 pmRNSTotal Voting Rights
27th Mar 201511:09 amRNSDirector/PDMR Shareholding
24th Mar 20157:03 amRNSCMA provisional clearance
18th Mar 201511:48 amRNSDirector/PDMR Shareholding
18th Mar 201511:45 amRNSDirector/PDMR Shareholding
16th Mar 20159:46 amRNSDirector/PDMR Shareholding
11th Mar 20153:07 pmRNSTotal Voting Rights
5th Mar 20154:57 pmRNSHolding(s) in Company
3rd Mar 201510:58 amRNSDirector/PDMR Shareholding
27th Feb 20155:27 pmRNSDirector Declaration
26th Feb 20157:01 amRNSAcquisition
26th Feb 20157:01 amRNSFinal Results
13th Feb 20157:00 amRNSHolding(s) in Company
6th Feb 20157:00 amRNSAcquisition of Spikes Cavell
3rd Feb 20157:00 amRNSBlocklisting Interim Review
3rd Feb 20157:00 amRNSHolding(s) in Company
30th Jan 201511:43 amRNSHolding(s) in Company
27th Jan 20156:28 pmRNSHolding(s) in Company
23rd Dec 20143:01 pmRNSDirector/PDMR Shareholding
19th Dec 20147:00 amRNSAcquisition of Total Objects completed
9th Dec 20143:09 pmRNSTotal Objects Acquisition to Complete
5th Dec 20144:03 pmRNSDirector/PDMR Shareholding
4th Dec 20147:00 amRNSAgencyport CMA Referral
3rd Dec 20141:48 pmRNSHolding(s) in Company
2nd Dec 20143:14 pmRNSAgencyport CMA Update
27th Nov 201410:51 amRNSDirector/PDMR Shareholding
27th Nov 20147:00 amRNSInvestor Seminar
26th Nov 201412:46 pmRNSTotal Voting Rights
21st Nov 20141:01 pmRNSDirector Declaration
14th Nov 20147:51 amRNSWorkers' Compensation contract
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20145:12 pmRNSBlocklisting Interim Review
20th Oct 20142:59 pmRNSDirector/PDMR Shareholding
3rd Oct 201412:20 pmRNSBlocklisting Interim Review
1st Oct 20147:00 amRNSAgencyport CMA Order
24th Sep 20144:36 pmRNSDirector/PDMR Shareholding
17th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 201410:21 amRNSHolding(s) in Company
29th Aug 201411:11 amRNSDirector/PDMR Shareholding
12th Aug 20145:21 pmRNSTotal Voting Rights
1st Aug 20141:04 pmRNSBlocklisting Interim Review
31st Jul 20147:00 amRNSHalf Yearly Report
30th Jul 20147:00 amRNSTakes full ownership of Fondsdepot Bank
14th Jul 20145:31 pmRNSHolding(s) in Company
8th Jul 20147:00 amRNSMM4 amendment to earn-out terms
4th Jul 20147:00 amRNSAcquisition
3rd Jul 20147:00 amRNSAcquisition
24th Jun 20145:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.